Clover Leaf Capital Corp. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021
Current assets:
Cash
Prepaid expenses
Total current assets
Deferred offering cost
Prepaid expenses – long term portion
Investments and cash held in Trust Account
Total Assets

Liabilities, Redeemable Common Stock and Stockholders’ Deficit
Accrued costs and expenses
Income taxes payable
Excise Tax Payable
Promissory note to Related Party
Related Party
Total promissory note to Related Party
Due to related party
Related Party
Total due to related party
Total current liabilities
Deferred underwriting commissions
Total Liabilities
Redeemable Common Stock:
Class A common stock subject to possible redemption, 1,048,796 and 1,251,156 Class A common stock shares at redemption value of $12.37 and $11.85 per share at June 30, 2024 and December 31, 2023, respectively
Stockholders’ Deficit:
Common stock value
Class A Common Stock
Class B Common Stock
Total common stock value
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 3,457,807 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively
Additional paid-in capital
Accumulated deficit
Total Stockholders’ Deficit
Total Liabilities, Redeemable Common Stock and Stockholders’ Deficit

Comments